Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis

被引:231
作者
Gerwins, P
Sköldenberg, E
Claesson-Welsh, L [1 ]
机构
[1] Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden
[2] Univ Uppsala, Childrens Hosp, Dept Surg Sci, Sect Paediatr Surg, S-75185 Uppsala, Sweden
关键词
angiogenesis; VEGF; FGF; signal transduction; oncology;
D O I
10.1016/S1040-8428(00)00062-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis, formation of new vessels from pre-existing ones, results from stimulation of endothelial cells, which line the vessel wall. These cells will leave their resting state and start to digest the basement membrane, proliferate, migrate and eventually differentiate to form a hollow tube. All these steps can be induced by growth factors and this review will focus on two important types of angiogenic growth factors, vascular endothelial growth factor (VEGF; also denoted vascular permeability factor, VPF) and fibroblast growth factor (FGF). Both types of factors bind to cell surface expressed receptors, which are ligand-stimulatable tyrosine kinases. Binding of the growth factors to their receptors leads to activation of the intrinsic tyrosine kinase and signal transduction to downstream signalling cascades. This results in transcriptional changes and biological responses. The molecular aspects of signalling cascades critical for endothelial cell proliferation and migration are beginning to be delineated. In contrast, signalling cascades leading to endothelial cell differentiation remain to be determined. Angiogenesis is essential for a number of physiological events such as embryonic development, ovulation, and wound healing. It has become increasingly clear that a number of diseases depend on angiogenesis. For future development of therapeutic tools, it is important to understand the molecular mechanisms that regulate angiogenesis. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 96 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[3]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[4]   Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium - A study of aortic and microvascular endothelial cell lines [J].
Bastaki, M ;
Nelli, EE ;
DellEra, P ;
Rusnati, M ;
MolinariTosatti, MP ;
Parolini, S ;
Auerbach, R ;
Ruco, LP ;
Possati, L ;
Presta, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :454-464
[5]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[6]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[7]  
Breier G, 1997, THROMB HAEMOSTASIS, V78, P678
[8]   Molecular mechanisms of blood vessel formation [J].
Bussolino, F ;
Mantovani, A ;
Persico, G .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (07) :251-256
[9]  
Cao Y, 1998, Prog Mol Subcell Biol, V20, P161
[10]   In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor vascular endothelial growth factor [J].
Cao, YH ;
Linden, P ;
Shima, D ;
Browne, F ;
Folkman, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) :2507-2511